Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Anavex Life Sciences Corp. (AVXL) had Current Ratio of 6.74 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.20M |
|
-- |
|
-- |
|
$12.51M |
|
$-12.51M |
|
$1.32M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-12.51M |
|
$-12.51M |
|
85.07M |
|
85.07M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$117.14M |
|
-- |
|
-- |
|
$117.14M |
|
$17.38M |
|
-- |
|
-- |
|
$17.38M |
|
$99.76M |
|
$99.76M |
|
$99.76M |
|
85.33M |
|
| Cash Flow Statement Financials | |
$-17.98M |
|
-- |
|
$1.56M |
|
$132.19M |
|
$115.77M |
|
$-16.42M |
|
$3.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
6.74 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.22% |
|
-11.22% |
|
-9.56% |
|
-11.22% |
|
$1.17 |
|
$-0.21 |
|
$-0.21 |
|